Sanofi Updates Financials Amid Opella Stake Transfer
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
Sanofi Hits 23-week Low
Sanofi's Multiple Sclerosis Therapy Tolebrutinib Gets US FDA's Breakthrough Designation
Gilead Sciences Names Dietmar Berger as Chief Medical Officer
Sanofi's Combo Vaccines Gain FDA Fast Track Designation
Antisense & RNAi Therapeutics Market Report 2024, Featuring Profiles of Alnylam Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, GSK, Ionis Pharmaceuticals, Sanofi, Sarepta Therapeutics & More - ResearchAndMarkets.com
Express News | Sanofi's Dual Influenza-COVID-19 Vaccines Receive FDA Fast Track Designation For Individuals 50 Years Of Age And Older
Press Release: Two Combination Vaccine Candidates for Prevention of Influenza and COVID-19 Granted Fast Track Designation in the US
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF) and NovoCure (NVCR)
AQEMIA Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting With London, UK
Express News | Sanofi : Jefferies Cuts Target Price to $63.5 From $66.5
Sanofi Says New Data for Sarclisa Combinations Shows Durable, Long-term Responses for Multiple Myeloma
Press Release: ASH: Sarclisa Combinations Demonstrated Significant Benefits in Newly Diagnosed Multiple Myeloma Patients
Sanofi's ITP Treatment Meets Primary, Secondary Endpoints in Phase 3 Study
Press Release: ASH: Rilzabrutinib Demonstrated Significant Patient Benefit in the First Positive Phase 3 Study of a BTK Inhibitor in ITP
Express News | Reuters Agriculture & Energy Policy Reporter Leah Douglas Posts On X "SCOOP: The USDA Is Issuing a Federal Order Mandating the National Milk Supply Be Tested for Bird Flu. Testing Will Begin Dec. 16 in Six States: CA, CO, MI, MS, PA, OR. Bird Flu Has...
Indapta Therapeutics Announces Clinical Study Collaboration With Sanofi on Multiple Myeloma Program
Press Release: Availability of the Revised Financial Statements for Sanofi Excluding Opella
Express News | Nuvig Therapeutics: Financing Was Co-Led by Sanofi Ventures, Blue Owl Healthcare Opportunities and Norwest Venture Partners
No Data